Sun Pharma Q4 net profit zooms over two-fold to Rs 894.15 crore

NEW DELHI: Drug major Sun Pharmaceutical Industries on Thursday reported an over two-fold jump in consolidated net profit to Rs 894.15 crore for the quarter ended March 2021, mainly on account of robust performance in the Indian market.
The company had posted a net profit of Rs 399.84 crore in the corresponding period of the previous fiscal, Sun Pharma said in a regulatory filing.
Consolidated total revenue from operations stood at Rs 8,522.98 crore for the quarter under consideration. It was Rs 8,184.94 crore in the same period a year ago, it added.
For the full fiscal 2020-21, the company posted a net profit of Rs 2,903.82 crore as against Rs 3,764.93 crore in the previous financial year.
The company’s total revenue from operations stood at Rs 33,498.14 crore for the financial year ended March 2021. It was Rs 32,837.50 crore in FY20, it added.
“FY21 was a year marked by a highly…

Source link